Literature DB >> 19657234

Possible angiogenic roles for claudin-4 in ovarian cancer.

Jianghong Li1, Srinivasulu Chigurupati, Rachana Agarwal, Mohamed R Mughal, Mark P Mattson, Kevin G Becker, William H Wood, Yongqing Zhang, Patrice J Morin.   

Abstract

Claudin proteins are frequently overexpressed in various tumors such as breast, prostate and ovarian cancer. While their functions in cancer have not been completely elucidated, roles in survival, adhesion and invasion have been suggested. In order to clarify the roles of claudins in ovarian cancer, we have performed gene expression profiling of ovarian surface epithelial cells overexpressing claudin-4 and compared the expression patterns to the parental, non-expressing cells. Claudin-4 expression leads to the differential expression of several genes, including many that have previously been implicated in angiogenesis. In particular, angiogenic cytokines, such as IL-8, were found elevated while genes of the angiostatic interferon pathway were found downregulated. In vitro assays show that claudin-4-expressing cells produce factors that can stimulate angiogenesis as measured by tube formation and migration in HUVEC cells. In addition, an in vivo mouse dorsal skinfold assay confirms that cells expressing claudin-4 secrete factors that can mediate angiogenesis in the dorsal skin of mice. Our data suggest a novel function for claudin-4 in cancer and provide an additional rationale for its common overexpression in human tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657234      PMCID: PMC2795001          DOI: 10.4161/cbt.8.19.9427

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  57 in total

1.  The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.

Authors:  R M Strieter; P J Polverini; S L Kunkel; D A Arenberg; M D Burdick; J Kasper; J Dzuiba; J Van Damme; A Walz; D Marriott
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

2.  Inhibition of cell motility by interferon.

Authors:  D Brouty-Boyé; B R Zetter
Journal:  Science       Date:  1980-05-02       Impact factor: 47.728

3.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; M Glass; M D Burdick; R M Strieter
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes.

Authors:  N Auersperg; S L Maines-Bandiera; H G Dyck; P A Kruk
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

5.  Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity.

Authors:  J R Testa; L A Getts; H Salazar; Z Liu; L M Handel; A K Godwin; T C Hamilton
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.

Authors:  M Leunig; F Yuan; M D Menger; Y Boucher; A E Goetz; K Messmer; R K Jain
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

7.  Dorsal skinfold chamber technique for intravital microscopy in nude mice.

Authors:  H A Lehr; M Leunig; M D Menger; D Nolte; K Messmer
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.

Authors:  Melissa L Petreaca; Min Yao; Yan Liu; Kathryn Defea; Manuela Martins-Green
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

9.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

Authors:  H F Dvorak; I Gresser
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

View more
  17 in total

Review 1.  Emerging multifunctional roles of Claudin tight junction proteins in bone.

Authors:  Fatima Z Alshbool; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-04-23       Impact factor: 4.736

2.  Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.

Authors:  G W Huang; X Ding; S L Chen; L Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-07       Impact factor: 4.553

3.  Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.

Authors:  Marie Ogawa; Takashi Kojima; Masayuki Someya; Kazuaki Nomura; Akira Takasawa; Masaki Murata; Satoshi Tanaka; Tsuyoshi Saito; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2012-04-29       Impact factor: 4.304

Review 4.  Claudins and alveolar epithelial barrier function in the lung.

Authors:  James A Frank
Journal:  Ann N Y Acad Sci       Date:  2012-06       Impact factor: 5.691

5.  Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses.

Authors:  Atsushi Kawabata; Naomi Ohta; Garret Seiler; Marla M Pyle; Susumu Ishiguro; Yong Qing Zhang; Kevin G Becker; Deryl Troyer; Masaaki Tamura
Journal:  Cytotherapy       Date:  2013-03-07       Impact factor: 5.414

Review 6.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

7.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

8.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

Review 9.  Emerging roles of claudins in human cancer.

Authors:  Mi Jeong Kwon
Journal:  Int J Mol Sci       Date:  2013-09-04       Impact factor: 5.923

Review 10.  Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

Authors:  Diana P English; Alessandro D Santin
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.